Malignant Digestive System Neoplasm — Trials

Malignant Digestive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

19,108 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,262
Recruiting: 2,364
Ph III recruiting: 291
Growth YoY: +11.7%
Industry share: 21%
Top sponsor: Fudan University
Termination share: 28.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2,001)

clinicaltrialsPublishedShowing 301–350 of 1,100 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07042919	Zanzalintinib in Second Line and Beyond for the Treatment of Advanced Liver Cancer	recruiting	Phase 1 / Phase 2	59	Devalingam MahalingamOTHER	1	Jun 25, 2026	clinicaltrials
NCT07669220	A Multicenter, Randomized Controlled Phase II Study of Short-Course Radiotherapy Followed by Sequential PD-1 Inhibitor and FOLFOX Chemotherapy Versus Long-Course Chemoradiotherapy for High-Risk Locally Advanced pMMR/MSS Lower Rectal Adenocarcinoma (STAR Trial)(STAR)	recruiting	Phase 2	76	Sixth Affiliated Hospital, Sun Yat-sen University